Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
887.58
-21.71 (-2.39%)
At close: Mar 4, 2026
3.14%
Market Cap 48.18B
Revenue (ttm) 26.61B
Net Income (ttm) 3.67B
Shares Out 52.98M
EPS (ttm) 69.33
PE Ratio 13.12
Forward PE n/a
Dividend 40.00 (4.56%)
Ex-Dividend Date Apr 18, 2025
Volume 10,041
Average Volume 23,437
Open 905.00
Previous Close 909.29
Day's Range 881.22 - 919.95
52-Week Range 793.00 - 1,241.00
Beta -0.03
RSI 33.84
Earnings Date Mar 26, 2026

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, an... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,376
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2024, Highnoon Laboratories's revenue was 24.63 billion, an increase of 24.60% compared to the previous year's 19.77 billion. Earnings were 3.39 billion, an increase of 38.44%.

Financial Statements

News

There is no news available yet.